Juvenile‐Onset Recurrent Respiratory Papillomatosis and Human Papillomavirus Vaccine Uptake: A 19‐Year Retrospective Cohort Study
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70141 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2026. Verfasst von Alexandra F Corbin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Respiratory Tract Infections, Papillomavirus Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate 19‐year trends in juvenile‐onset recurrent respiratory papillomatosis incidence and treatment utilization in the context of increasing human papillomavirus vaccine uptake. Study Design Retrospective cohort study.
Setting
TriNetX United States Collaborative Network.
Methods
Children 18 years of age or younger with juvenile‐onset recurrent respiratory papillomatosis diagnosed between January 1, 2006, and December 31, 2024, were identified using International Classification of Diseases codes. Annual encounter‐based incidence per 100,000 patients was calculated for both juvenile‐onset recurrent respiratory papillomatosis and human papillomavirus vaccination. Within the pediatric juvenile‐onset recurrent respiratory papillomatosis cohort, annual utilization of major treatment modalities, including bevacizumab, cidofovir, lesion excision, and tracheostomy, was assessed.
Results
A total of 1854 children met inclusion criteria (mean age 7.9 ± 5.7 years). Juvenile‐onset recurrent respiratory papillomatosis incidence declined by 65.2%, from 3.1 cases per 100,000 in 2006 to 1.1 cases per 100,000 in 2024 ( P < .001). Human papillomavirus vaccine incidence increased by 1448.1%, from 45.5 to 704.4 cases per 100,000 patients over the same period ( P < .001). Annual juvenile‐onset recurrent respiratory papillomatosis incidence was inversely correlated with human papillomavirus vaccine incidence ( r = −0.892; P < .001). Within the pediatric juvenile‐onset recurrent respiratory papillomatosis cohort, use of bevacizumab and cidofovir increased significantly, whereas lesion excision and tracheostomy incidence remained stable.
Conclusion
Rising human papillomavirus vaccine uptake is associated with a significant reduction in encounter‐based juvenile‐onset recurrent respiratory papillomatosis incidence at the population level. Surgical excision remains the predominant management approach, with limited adoption of adjuvant therapies despite recent increases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, New York, USA.
- Department of Otolaryngology, Head and Neck Surgery, University of Calgary, Calgary, Alberta, Canada.
- Department of Otolaryngology, Head and Neck Surgery, Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, New York, USA.
ORCID-Profile: Alexandra F Corbin, Nick Sahlollbey, Gaayathri Varavenkataraman, Murilo de Santana Hager, Beatrice R Bacon, Michele M Carr
Zitieren
APA
Corbin, A. F., Sahlollbey, N., Varavenkataraman, G., de Santana Hager, M., Bacon, B. R., & Carr, M. M. (2026). Juvenile‐Onset Recurrent Respiratory Papillomatosis and Human Papillomavirus Vaccine Uptake: A 19‐Year Retrospective Cohort Study. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70141
Vancouver
Corbin AF, Sahlollbey N, Varavenkataraman G, de Santana Hager M, Bacon BR, Carr MM. Juvenile‐Onset Recurrent Respiratory Papillomatosis and Human Papillomavirus Vaccine Uptake: A 19‐Year Retrospective Cohort Study. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70141
BibTeX
@article{Corbin2026,
author = {Corbin, Alexandra F and Sahlollbey, Nick and Varavenkataraman, Gaayathri and de Santana Hager, Murilo and Bacon, Beatrice R and Carr, Michele M},
title = {Juvenile‐Onset Recurrent Respiratory Papillomatosis and Human Papillomavirus Vaccine Uptake: A 19‐Year Retrospective Cohort Study},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70141}
}
EUVIMED